SCHEMBL21936263

SCHEMBL21936263

CC(=N)c1cc(C)c(F)cc1NCC(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24901054 0.90 IL1B (0.32) —
SCHEMBL24900925 0.77 IL1B (0.31) —
SCHEMBL21872420 0.74 — —
SCHEMBL24901197 0.73 — —
SCHEMBL21937319 0.71 — —
SCHEMBL21936262 0.71 — —
SCHEMBL15634988 0.70 CTSV (0.40) POLBMAPT
SCHEMBL25687069 0.67 TSHR (0.36) —
SCHEMBL21872491 0.66 IL1B (0.34) —
SCHEMBL13450312 0.66 NNMT (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback